drugset / Trial / NCT01731236

CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease

NCT01731236

Phase 0 Active not recruiting 100 enrolled The Cleveland Clinic
RandomizedParallel-groupOpen-labelBasic science

Summary

The principal goal for the study is to examine the role gut flora plays in modulating metabolism of dietary carnitine and choline in humans.

Timeline

Start
2011-02-11
Primary completion
2027-12
Completion
2029-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg Oral
Comparator Carnitine Small molecule 500 mg Oral
Comparator Choline Other / unclassified 500 mg Oral
Comparator Ciprofloxacin Small molecule 500 mg Oral
Comparator Metronidazole Small molecule 500 mg Oral
Comparator Neomycin Unknown 1 g Oral
Comparator Vancomycin Other / unclassified 125 mg Oral

Indications

No indication recorded.